Thompson Craig B. 4

What Happened
Craig B. Thompson, a director of Charles River Laboratories International, Inc. (CRL), was granted 1,438 restricted stock units (RSUs) on May 8, 2026. The award is recorded at $177.62 per share, for a reported aggregate value of approximately $255,418. This was an award/compensation grant (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-05-08; Form filed: 2026-05-12 (filed four days after the transaction; may be later than the typical 2-business-day Form 4 deadline).
• Transaction type/code: Award/Grant (A). Price per share reported: $177.62; total reported value: $255,418.
• Shares granted: 1,438 RSUs (unvested at grant).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The RSUs vest on the earlier of May 8, 2027 or the business day prior to the Company's next annual meeting of shareholders.

Context
This was a standard compensation award to a board member (RSUs) rather than a market purchase or sale. Because the units are unvested, they do not represent immediately tradable shares until vesting conditions are met. The later filing date is noted in the Form 4; retail investors should treat this as a routine director grant and not necessarily as a direct signal of buying or selling intent.